SciELO - Scientific Electronic Library Online

 
vol.15 issue1CELLULAR SUSPENSIONS ESTABLISHMENT OF Bixa orellana L., PHENOLIC COMPOUNDS PRODUCERS WITH POTENTIAL ANTIOPHIDIC ACTIVITYCOMPLEMENTARY FINDINGS ON THE ANTIMALARIAL ACTIVITY AND TOXICITY OF METHYLENE BLUE author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Vitae

Print version ISSN 0121-4004

Abstract

SANDOVAL, Gloria A; VACCA G, Claudia P  and  OLARTE, Jorge. VITAL MEDICINES NOT AVAILABLE: NATIONAL AND INTERNATIONAL REGULATION ANALYSIS, UPDATE PROPOSAL OF NATIONAL LIST. Vitae [online]. 2008, vol.15, n.1, pp.77-89. ISSN 0121-4004.

A comparative revision was carried out on the national and international policies and regulations about access of orphan and/or vital drugs. An analysis of: orphan drugs' list from USA, European Union and all applications for importation of not available drugs submitted by the Drug Regulatory Authority (INVIMA) until 2006; an informal consultation with health care providers, insurance companies and distributors of vital medicines, were included, in order to improve the actual vital drugs list within the frame of public health programs. The analysis included all drugs that have been protected by Decree 2085 from 2002, as well as the imported drugs by the Ministry of Social Welfare under the public health program. 26 of 107 proposed drugs match the lists of orphan drugs from the countries analyzed and 12 are protected with exclusivity by decree 2085 from 2002.

Keywords : orphan drugs; exceptional drugs; rare disease; neglected disease; legislatio.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License